#wockhardt
Wockhardt secures US FDA approval for antibiotic Zaynich
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibiotic
Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial results and the drug’s potential to treat severe drug-resistant infections boosted investor sentiment, helping the stock e…
Wockhardt stock rallies post - CDSCO nod for novel antibiotic
Stocks to Watch Today : Physicswallah , Swiggy , Q - Line Biotech , Lupin , Wockhardt , Ashok Leyland , GMR Airports , PG Electroplast , West Coast Paper in focus on 29 May
Wockhardt gets CDSCO nod for Zaynich antibiotic
Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to treat complicated urinary tract infections in adults. The approval follows successful clinical trials. Zaynich shows potenti…
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?
Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by strong earnings reports, a fall in oil prices, and renewed market optimism. Key gainers included Coforge, SRF, and Wock…